Are your patients ready to embrace change?


Happy New Year to you all. I'm sure, by now, the memories of Christmas have faded and the New Year's resolutions have already been broken but I do hope you used the holiday season to recharge your batteries, ready to face whatever 2007 may bring.

We kick off this year with a special focus on the ageing eye - presbyopia. As with all surgical procedures, we highlight the importance of patient communication here. Indeed, some specialists believe that effective communication could yield a practice with a near 100% patient satisfaction record. We have tried our best to cover this diverse and complex area of research, but I'm sure that the best is yet to come. As the year unfolds, I imagine we will be seeing the treatment of presbyopia evolve significantly as the pace of research and development looks set to step up a gear.

Going back to the subject of communication, I was talking with my grandmother over the Christmas break about her progress since she had undergone cataract surgery two months earlier. Now, I admit that English is not her first language and my spoken Greek is far from perfect but, with the help of my trusted translator (my Mother), I asked her how she felt following her surgery. She said that she felt fine but didn't understand why her vision was now blurred with her current prescription of spectacles. When I asked her to remove her spectacles and look at the television, I asked her if she could see better. She confirmed that she could but she insisted on keeping her spectacles on as she was afraid of "developing a headache".

I'd like to thank you for joining us at the beginning of what I'm sure will be another great year.

Fedra Pavlou

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.